Microchip Technology (MCHP)

Total return at 5 years: 1.5%/year = -1.0% appreciation + 2.5% dividend. The target price ($70) is ex-dividend; the $9 in dividends collected over 5 years are added separately.

The methods disagree: one places the value today above the price ($74) and the other below.

Today — expensive, no margin of safety: at $74 trades ~14.6% above its value discounted to today (~$64); the expected return does not even reach the risk-free rate (4.5%).

At 5 years — Preserva valor: the target price ($70) plus dividends yield just enough to preserve nominal capital, below the required 4% floor.

The bridge: the return at 5 years falls below the risk-free rate (4.5%) — which is why there is not even a discount to today's value. To require a 15% annual return, it would need to be bought at ~$41.

Educational / informational. Does not constitute investment advice.

The inverse approach: instead of projecting growth to obtain the value, the market price ($74) is taken as given and it solves for what annual owner-earnings growth would need to hold for 5 years for the present value —at the method's rate (4.5%, no-growth terminal)— to equal that price. It is the disconfirmation test: the expectations the price already pays for, contrasted against the method's projection.

The market discounts less growth (10.9%/year) than we project (18.0%/year) → if the base case holds, there is margin: perception is more pessimistic than the estimated reality.

That growth implies ~$2.1 bn of owner earnings in year 5 (vs ~$2.9 bn of our base case). It recalculates if the DCF assumptions are edited.

Year-by-year projection of the selected scenario. From each year, two versions of the flow are derived: growth FCF (operating flow − total capex, the cash surplus) and maintenance FCF (the owner earnings: what the business yields if it only sustains its capacity). Cash accumulates the retained surplus —what is not returned as dividend or buyback—, so that EV falls and multiples compress going forward. The valuation is done on EV/NOPAT normalizado a mediados de ciclo (semiconductor de control embebido). In edit mode, revenue, margins, capex, and exit multiples can be adjusted.

Year 0 = the twelve months ended June 30, 2026 (10-Q for the first quarter of fiscal 2027): revenue of US$5,122 million and an operating margin of 15.5%, emerging from the contraction (the fiscal year ended March 31, 2026 delivered US$4,713.1 million and 10.4%, the trough). The year-0 level is the real one; the earnings being valued are normalized to mid-cycle, not the trough (§2). The year-1 starting point is anchored to the guidance published on August 6, 2026 for the September quarter — revenue up 7% to 9% on the June quarter (US$1,485 million, which beat the top of the prior guidance), a midpoint of about US$1,604 million and year-over-year growth of ~40.6% per the company — which annualized equates to about US$6,416 million; the year-1 path (US$6,521 million) adds moderate sequential growth over the following three quarters. That first-year jump is a recovery in level after the inventory correction, not a durable rate: it is declared as such and the path returns to the structural band (5% to 6%) from year 2. The operating margin expands through three verifiable levers: fab utilization rising again, operating leverage on operating expenses growing more slowly than revenue, and the amortization of acquired intangibles winding down on its own per the schedule in Note 8 of the 10-K (US$454.8 · 344.0 · 270.2 · 258.1 · 231.3 million for fiscal years 2027 to 2031). The year-5 operating margin (32.2%) stays below fiscal 2023's 36.9% and fiscal 2024's 33.7%: the normalization goes to the midpoint of the range, not to the peak. The 19.4% tax rate is the real effective rate of fiscal 2024 (US$459.0 on US$2,365.9 million of pre-tax income), the last year with a normalized earnings base; the fiscal 2026 effective rate (15.9%) is distorted because fixed tax credits weigh enormously on depressed pre-tax income. The share path models no buybacks (there were none in fiscal 2026) and no stock-based compensation dilution (already expensed within the operating margin): it captures only the mandatory conversion of the Series A preferred stock on 15 March 2028, which converts 1,485,000 securities into between 16.0060 and 19.6080 common shares each depending on the market price at that time — hence the bear case, with a lower price, suffers more dilution. The capped calls purchased for US$55.1 million (cap price US$71.40) could reduce that dilution, but the filing does not quantify the effect and it is not credited. Cash does not accumulate: the dividend paid (US$984.0 million on the common stock plus US$108.5 million on the preferred) exceeds the fiscal year's free cash flow, so retention is nil and the cash balance stays flat.

Today's elevated multiple is the price of growth: if the business grows, the entry point cheapens on its own going forward (the metric grows while EV stays roughly flat). The exit multiple at 3 years is higher than the terminal at 5 years —at 3 years there is more growth still ahead—, so the value curve shows whether value creation is concentrated in the early or the later years. The required return is applied to the base scenario.

They are valued separately, with their own rationale, and are not incorporated into the base or the verdict (they are excess return). When assigning them value — in Editmode —, the total with optionalities updates live, without moving the base.

The verdict, the base CAGR, and the margin of safety are always calculated on the base; optionalities do not alter them (with optionalities at $0 they do not move).

Each card fixes a required annual return and answers: if the business is worth $70 in 5 years, what is the maximum that can be paid today to obtain that return? Since it now trades at $74, the margin of safety is how much cheaper the market is than that maximum. The three thresholds: 4% covers inflation (the floor), 10% is the long-term average return, and 15% is the level of a great investment.

With a target price of $70 in 5 years plus $9 of dividends collected (the dividend adds to the return, not to the price) and a required return of 4.5% annually, the maximum to pay today is $64. Against the current market price ($74), the margin of safety is -14.6% (trades above the maximum → a premium is paid) and the total return at that price would be 1.5% annually.

• Entry multiple. On trailing-twelve-month earnings the multiple carries no economic meaning because earnings are at the trough; on normalized year 5 earnings the entry equals 15×.
• Margin of safety. No margin of safety: at this price capital is preserved, but it is not bought below its value.
• Sensitivity to the normalized margin. Value depends almost entirely on where the operating margin settles: the difference between the fiscal 2024 level and the projected one moves terminal value disproportionately.
• Dividend. A yield of 2.5%, frozen at US$0.455 per quarter since 2024 and paid above the year's free cash flow.

Each margin over sales, year by year: historical (solid line) → projection (dotted).

• ✕ ROIC exceeds the cost of capital (~10%)
• ✓ CFROIC backs up the ROIC (168%, cash vs. accruals)
• ✓ Healthy balance sheet (low corporate debt)
• ✓ Durable competitive moat (multiple advantages)

• Cash generation through the downturn. Free cash flow stayed positive even in the worst year (US$772.1 million in fiscal 2025) thanks to the cut in capital investment.
• Return on capital against the 10% bar. Well below the bar on trough earnings and on an invested capital base that carries two decades of acquisitions; on normalized earnings it sits above.
• Stock-based compensation. US$255.4 million, 29.3% of the year's free cash flow: material against the cash flow even though it is only 5.4% of revenue. It is expensed inside operating income.
• Reinvestment runway. Capital investment paused through fiscal 2027 and approximately US$100 million stated for the next twelve months; installed capacity is sufficient to grow without spending much.

Annual levels from the official filing (10-K); the % over each bar is the year-over-year (YoY) growth vs the prior year.

The four series tell the same story from different angles. Operating cash flow collapsed from US$2,892.7 to US$898.1 million between fiscal 2024 and 2025 and barely recovered to US$962.1 million in 2026, because earnings recovery arrived late in the fiscal year. Capital investment was cut from US$285.1 to US$91.1 million when factories 4 and 5 expansions paused—the fastest defensive lever for a manufacturer with in-house capacity, and explains why free cash flow stayed positive in the worst year. Stock-based compensation did the opposite: rose 41.6% in fiscal 2026 to US$255.4 million, 29.3% of free cash flow, because retaining engineers during a contraction is expensive. And dividends remained frozen at US$0.455 quarterly since 2024: the company states its intent is to maintain current level, not increase.

The % are the annual (year-over-year) growth: each year —historical and projected— vs the prior one; the TTM (trailing 12m) vs the TTM of a year ago, to avoid overlapping windows. The historicals are exact figures from the official filings; the projected years come from the year-by-year model (the intermediate years without their own series are interpolated between the anchors). The projected columns (+1y…+5y) are 12-month windows counted from the TTM close (30-jun-2026): the projection starts from the most recently reported data, not the fiscal year. The projected base is realistic and unbiased — the risk discount is applied at the end, via the required return. The rationale for each metric is in the (i).

• Cycle inflection. Fiscal 2026 recovered level broadly: revenue of US$4,713.1 million, 7.1% above fiscal 2025, with all three product lines and all three geographies growing after the worst cycle year.
• Next-quarter guidance. The June quarter (US$1,485 million, +38.0% year over year) beat the top of guidance; for September the company guides +7% to +9% sequential (~40.6% year over year at the midpoint).
• Room left in channel restocking. Distributor inventory stands at 26 days, near the low end of the historical 17 to 43 day range: little restocking room remains.
• Long-term level. The projected year 5 does not regain the fiscal 2023 revenue peak, which was inflated by shortage-era over-ordering.

• Recurrence and predictability. No broad contractual recurrence: long-term supply agreements exist with some customers, anticipating a deposit for assured capacity over three to five years, but the bulk of volume depends on end demand and proved highly volatile in this cycle.
• Customer concentration. Approximately 101,000 unique customers and none exceeded 10% of sales in the last three fiscal years; real concentration is in the channel, with Arrow Electronics at 12% of revenue and 14% of accounts receivable—the only customer or distributor exceeding the 10% threshold on either metric.
• Pricing power. Prices in the proprietary microcontroller and analog lines held stable against the price erosion typical of the sector, but the non-proprietary portion of analog does fluctuate.
• Behavior through the downturn. Revenue fell 48% from peak to trough and operating income 90%: the contraction was far deeper than that of its peers in the same archetype.

Not all debt is equal: only the structural needs refinancing; the rest is operational (self-liquidating).

Structural debt is what is exposed to the contraction phase of the cycle; operational debt (leases, matched funding) self-liquidates with the business.

• ✕Leverage (net debt / EBITDA)Net debt / EBITDA 3.5x
• !Interest coverage (EBIT / interest)3.6x
• –Liquidity (current ratio)no data
• ✓Cash quality (CFROIC vs ROIC)CFROIC backs 168% of ROIC
• ✕Value creation (ROIC − 10% bar)-7pp
• ✓Malinvestment test (capex vs incremental ROIC)Capex/D&A 0.1x — no over-investment
• !Float / working capitalConsumes cash $0.2 bn (positive WC)
• !Dilution (SBC % of revenue + shares)SBC 5.4% of revenue

A traffic-light interpreted by the method (not generic): float (negative WC) adds up, capex is judged by incremental ROIC (malinvestment test), and a lender is not subjected to corporate solvency. The (i) shows the derivation of each number.

• Debt structure. Gross debt of US$5,536.9 million—commercial paper US$349.0 million, unsecured senior notes US$3,349.0 million and convertible debt US$2,187.9 million—against US$240.3 million of cash as of March 31, 2026, with no short-term liquid investments.
• Leverage covenant. The maximum ratio required steps down from 4.75 times in March 2026 to 3.50 times at the end of the covenant relief period, which forces earnings to recover on schedule.
• Maturity wall. 34% of debt (US$1,900 million) matures in a single fiscal year, 2030; next maturity is US$386.9 million in 2027, followed by US$1,000 million in each of fiscal 2028 and 2029.
• Convertible preferred. US$1,485 million at 7.50% consuming US$111.2 million a year ahead of the common holder and converting mandatorily on March 15, 2028.

How cash comes in and how it is deployed. In green, the business's own cash (the owner-FCF it generates and reinvests); in gray, the float and credit — customer and funding money, which is not the shareholder's.

The fiscal 2026 split is unusually extreme and tells the state of the balance sheet on its own: practically all allocated capital went to dividends — US$984.0 million to common holders plus US$108.5 million to preferred holders — against just US$91.1 million of capital investment, with no buybacks and no acquisitions. The detail that matters is that this dividend exceeded the year's free cash flow (US$871.0 million) and coincided with the repayment of US$1,200 million of notes, covered with US$900 million of new convertible debt and US$173.7 million of net commercial paper. In other words: the stated priority was to protect the dividend and refinance, not to retain capital or repurchase stock at a depressed price.

Who owns the shares — the alignment and whether there is a controlling shareholder.

• Alignment. The chief executive owns 1.74% of the company, practically the whole insider stake held by directors and executive officers as a group (1.79%).
• Capital allocation. It sustained the dividend above free cash flow, funding it partly with new debt, and repurchased no stock with the price at the low of the cycle.
• Execution of the recovery plan. Closure of Tempe (Arizona) factory and inventory reduction of US$258.1 million between fiscal 2025 close (US$1.29 billion) and fiscal 2026 close (US$1.04 billion), with 7.1% revenue recovery after previous year's 42.3% decline.
• Succession. Chief executive of seventy years who had retired once, designated permanent July 2, 2025, and chief operating officer resignation announced July 23, 2026.

• Emotional selling after two years of falling results: revenue collapsed 42.3% in fiscal 2025 and net income fell to zero, driving out the investor who owned the company for its record of stability.
• Reported earnings hide the cash generation: acquired-intangible amortization took US$431.1 million out of fiscal 2026 operating income and the preferred dividend another US$111.2 million out of earnings attributable to common holders, so published earnings per share look far worse than what the business generates.
• The discount, however, is largely closed: the entry multiple on normalized earnings already discounts the full recovery. No source of divergence between perception and reality remains identifiable.

The method requires stating where the opportunity would come from, and in this case the honest conclusion is it no longer comes from anywhere obvious. The forced-sale phase is past: the market saw the broad recovery of fiscal 2026—all three lines and all three geographies growing—and repriced accordingly. What remains is a good franchise at a price that already incorporates normalization, with a leveraged balance sheet and preferred shares consuming cash flow ahead of ordinary equity. When no identifiable gap between perception and reality exists, prudence is to conclude the stock is not cheap but appears cheap through depressed accounting earnings.

The annual return (CAGR at 5 years) in each scenario, with the total period return below — the margin of safety made visual: upside range wide, downside range narrow.

Even in the bear scenario, the return holds at -11%/year (-43% total): the margin of safety protects the downside. The bull (+9%/year, +57% total) exceeds it comfortably — a favorable asymmetry, with a narrow downside range and a wide upside range.

• Cyclicality. Revenue contraction of 48% between fiscal 2023 and 2025, much deeper than same-archetype peers, with US$200.8 million in unabsorbed capacity charges still present in fiscal 2026.
• Copying and low-end competition. The 10-K states the company competes with entities it believes copied or reverse-engineered its proprietary lines in China and Taiwan, and warns some governments—"like China"—may be financially assisting new entrants; in September 2025 China's Ministry of Commerce opened an anti-dumping investigation on US-origin analog semiconductors.
• Geographic and regulatory exposure. Asia accounts for 49.9% of sales (China 18%, Taiwan 15%) and approximately 75% of revenue is to customers outside the United States; starting December 2027 US government agencies are prohibited from buying semiconductors from suppliers connected to SMIC or YMTC, and Microchip manufactures some production at SMIC.
• Malaysian tax assessment. Up to roughly US$480.2 million in taxes and penalties if the tax authority prevails; resolution could arrive within the next eighteen months.
• Dilution from the mandatory conversion. Between 23.8 and 29.1 million new common shares in March 2028 depending on the market price: the lower the stock, the greater the dilution.

Each thinker's analytical framework applied to our data.

• Buffett / Graham Quality + margin of safety

  Fails the quality gate: ROIC 3% does not clear the 10% bar.

• Peter Lynch Growth at a reasonable price (GARP)

  A fast grower growing 18% at a multiple/growth of 3.9 → expensive for its growth.

• Joel Greenblatt Cheap and high-return (Magic Formula)

  Earnings yield 2% (EBIT/EV) + ROIC 3% → falls outside the Magic Formula.

• Howard Marks Perception vs reality + cycle

  The price discounts 11% vs our 18%: perception is more pessimistic than reality, with an identified source of the discount.

• Seth Klarman Capital protection (bear scenario)

  Bear-scenario floor -14%/yr over 5y (material loss) → risk of permanent capital loss.

• Pat Dorsey Moat strength (Five Rules)

  A wide moat, stable; sources: switching costs, cost advantage, intangibles, efficient scale → passes the Five Rules.

• Aswath Damodaran Expectations implied by the price

  Justifying the price requires discounting 11%, within what we project (18%) — the story squares with the numbers.